Paper41999190
A Clinical-Radiomics Nomogram Predicts Early Tumor Necrosis After Transarterial Chemoembolization for Hepatocellular Carcinoma.
Wu XL and 5 others. Technol Cancer Res Treat, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. A Clinical-Radiomics Nomogram Predicts Early Tumor Necrosis After Transarterial Chemoembolization for Hepatocellular Carcinoma. Papers, record 41999190. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41999190
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- A Clinical-Radiomics Nomogram Predicts Early Tumor Necrosis After Transarterial Chemoembolization for Hepatocellular Carcinoma.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Liver Neoplasms | Major topic |
| Carcinoma, Hepatocellular | Major topic |
| Chemoembolization, Therapeutic | Major topic |
| Nomograms | Major topic |
| Humans | |
| Radiomics | |
| Female | |
| Necrosis | |
| Male | |
| Middle Aged | |
| Aged | |
| Treatment Outcome | |
| Prognosis | |
| ROC Curve | |
| Tomography, X-Ray Computed |
Source PubMed
References39
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29662837 | Patient Selection for Transarterial Chemoembolization in Hepatocellular Carcinoma: Importance of Benefit/Risk Assessment. | Liver Cancer | 2018 | https://conductscience.org/library/papers/29662837 | PubMed |
| 2 | 26762942 | 3D Quantitative tumour burden analysis in patients with hepatocellular carcinoma before TACE: comparing single-lesion vs. multi-lesion imaging biomarkers as predictors of patient survival. | Eur Radiol | 2016 | https://conductscience.org/library/papers/26762942 | PubMed |
| 3 | 31698504 | Prediction of Survival Among Patients Receiving Transarterial Chemoembolization for Hepatocellular Carcinoma: A Response-Based Approach. | Hepatology | 2020 | https://conductscience.org/library/papers/31698504 | PubMed |
| 4 | 17938396 | The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. | Ann Intern Med | 2007 | https://conductscience.org/library/papers/17938396 | PubMed |
| 5 | 38448905 | Construction of a prognostic model for hepatocellular carcinoma patients receiving transarterial chemoembolization treatment based on the Tumor Burden Score. | BMC Cancer | 2024 | https://conductscience.org/library/papers/38448905 | PubMed |
| 6 | 40075740 | Integrating CT Radiomics and Clinical Features to Optimize TACE Technique Decision-Making in Hepatocellular Carcinoma. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/40075740 | PubMed |
| 7 | 32060219 | Introduction to Radiomics. | J Nucl Med | 2020 | https://conductscience.org/library/papers/32060219 | PubMed |
| 8 | 36631548 | CT-radiomics and clinical risk scores for response and overall survival prognostication in TACE HCC patients. | Sci Rep | 2023 | https://conductscience.org/library/papers/36631548 | PubMed |
| 9 | 35070032 | Combined treatments in hepatocellular carcinoma: Time to put them in the guidelines? | World J Gastrointest Oncol | 2021 | https://conductscience.org/library/papers/35070032 | PubMed |
| 10 | 34765303 | Complete response at first transarterial chemoembolization predicts favorable outcome in hepatocellular carcinoma. | Am J Cancer Res | 2021 | https://conductscience.org/library/papers/34765303 | PubMed |
| 11 | 39747344 | Application of the Lasso regularisation technique in mitigating overfitting in air quality prediction models. | Sci Rep | 2025 | https://conductscience.org/library/papers/39747344 | PubMed |
| 12 | 35941241 | Analysis of Tumor Burden as a Biomarker for Patient Survival with Neuroendocrine Tumor Liver Metastases Undergoing Intra-Arterial Therapies: A Single-Center Retrospective Analysis. | Cardiovasc Intervent Radiol | 2022 | https://conductscience.org/library/papers/35941241 | PubMed |
| 13 | 21703196 | EASL and mRECIST responses are independent prognostic factors for survival in hepatocellular cancer patients treated with transarterial embolization. | J Hepatol | 2011 | https://conductscience.org/library/papers/21703196 | PubMed |
| 14 | 38606106 | A refined prediction model for survival in hepatocellular carcinoma patients treated with transarterial chemoembolization. | Front Oncol | 2024 | https://conductscience.org/library/papers/38606106 | PubMed |
| 15 | 37519801 | Radiomics features of computed tomography and magnetic resonance imaging for predicting response to transarterial chemoembolization in hepatocellular carcinoma: a meta-analysis. | Front Oncol | 2023 | https://conductscience.org/library/papers/37519801 | PubMed |
| 16 | 34729109 | Predicting early refractoriness of transarterial chemoembolization in patients with hepatocellular carcinoma using a random forest algorithm: A pilot study. | J Cancer | 2021 | https://conductscience.org/library/papers/34729109 | PubMed |
| 17 | 34907081 | Objective Response Predicts Survival in Advanced Hepatocellular Carcinoma Treated with Systemic Therapies. | Clin Cancer Res | 2022 | https://conductscience.org/library/papers/34907081 | PubMed |
| 18 | 30360019 | Clinical outcomes of patients with a single hepatocellular carcinoma less than 5 cm treated with transarterial chemoembolization. | Korean J Intern Med | 2019 | https://conductscience.org/library/papers/30360019 | PubMed |
| 19 | 23884657 | The Cancer Imaging Archive (TCIA): maintaining and operating a public information repository. | J Digit Imaging | 2013 | https://conductscience.org/library/papers/23884657 | PubMed |
| 20 | 30129899 | Baseline Volumetric Multiparametric MRI: Can It Be Used to Predict Survival in Patients with Unresectable Intrahepatic Cholangiocarcinoma Undergoing Transcatheter Arterial Chemoembolization? | Radiology | 2018 | https://conductscience.org/library/papers/30129899 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41999190
GET https://conductscience.org/api/papers/v1/41999190/references?page=2